Efficacy and Safety of Nintedanib in Patients with Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD): A Real-World Single Center Experience

Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD) is a severe and fatal manifestation of systemic autoimmune disorders. Therapies rely on immunomodulators but their efficacy in ILD progression remains uncertain. Nintedanib, an antifibrotic agent that slows pulmonary function decline, has...

Descripción completa

Detalles Bibliográficos
Autores principales: Boutel, Maria, Boutou, Afroditi, Pitsiou, Georgia, Garyfallos, Alexandros, Dimitroulas, Theodoros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093288/
https://www.ncbi.nlm.nih.gov/pubmed/37046439
http://dx.doi.org/10.3390/diagnostics13071221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093288/
https://www.ncbi.nlm.nih.gov/pubmed/37046439
http://dx.doi.org/10.3390/diagnostics13071221

Ejemplares similares